TNF and SAPHO syndrome: Furthermore, the signaling pathways involving IL-1 and TNF-α are central to the pathophysiology of SAPHO syndrome, supporting the use of biologic treatments such as TNF-α inhibitors and IL-1 receptor antagonists (6, 10, 18).